CSIRO moves towards Open Access for national benefit
Date posted – 17 March 2021 Media Release date – 3 March 2021 Research aimed at solving Australia’s greatest challenges will be made increasingly accessible as part of a shift towards ‘Open Access’ models at the national science…
ANDHealth Collaborates with US Healthcare Leader Anthem Inc. to Bring Innovative Australian Technologies to the US Market
Date posted – 17 March 2021 ANDHealth last week announced a joint effort with the Anthem Digital Incubator to facilitate and accelerate US market access and uptake for Australian digital health companies and their products and services. Anthem,…
PharmaLex broadens biopharma expertise
Date posted – 9 March 2021 The addition of ERA Consulting allows PharmaLex to further expand its geographic footprint as well as strengthens its biopharma capabilities Frankfurt, Germany – February 24, 2021: PharmaLex Group, a leading provider of…
Cartherics Announces Grant of European Patent
Date posted – 8 March 2021 First patented product to enter clinic within two years Cartherics Pty Ltd (Cartherics) announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects…
Monash University retains its spot as #2 in the world for Pharmacy and Pharmacology
Date posted – 4 March 2021 The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running. Pharmacy and Pharmacology remains Monash’s…
ALHI $28.9M MRFF GRANT REVOLUTIONISES LUNG FUNCTION SCANNING
Date posted – 4 March 2021 The Australian Lung Health Initiative (ALHI) is pleased to announce it has been granted $28.9 million in funding from the Australian Federal Government’s Medical Research Future Fund (MRFF) Frontier Health and Medical…
Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes
Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…
VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics.
16 February 2021 VivaZome Therapeutics Pty Ltd (“VivaZome”) and La Trobe University today announced that they have entered into a new collaborative research project focussed on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work…
TGA approves first Australian commercial CAR-T manufacturing site – bringing faster access to eligible Australians with life-threatening blood cancers
12 February 2021 • Kymriah® (tisagenlecleucel)[pronounced kim-RY-uh], a chimeric antigen receptor T cell (CAR-T) one-time treatment, will be the first commercially approved CAR-T therapy to be manufactured in Australia • Providing manufacturing capabilities in Australia will help reduce…
New appointments at Biointelect
12 February 2021 Biointelect has made several new appointments to its Sydney and Melbourne-based teams as it experiences strong growth across all its three main consulting workstreams: R&D strategy and planning, biotech commercialisation and strategic market access, health…
First-hand experience sparks Rhinomed to develop high comfort swab
Posted 10 December 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In April this year, as the world came to grips with the global COVID-19 pandemic, Rhinomed CEO Michael…
Monash University partners with HuiKang Bio-Tech to develop new class of anti-infectives
7 December 2020 Monash University has announced a collaboration with leading protein and peptide experts, HuiKang Bio-Tech, to develop a new class of anti-infectives. The collaboration is being led by Professor Ray Norton from the Monash Institute of…
